SJ
Sanjay Jivrajbhai Vaghani
About Sanjay Jivrajbhai Vaghani
Sanjay Jivrajbhai Vaghani has 3 years in corporate governance. Holds Partner and Managing Director roles. Currently with 6 companies, including Surat Institute Of Medical Science Llp and Universal Superspeciality Hospital Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Partner | 22 Dec 2022 | 2018 | Active | |
Universal Superspeciality Hospital Limited
U82990GJ2023PLC139251
|
Managing Director | 13 Oct 2023 | 2023 | Active |
Swastham Heart Care Private Limited
U86100GJ2025PTC164015
|
Director | 11 Jun 2025 | 2025 | Active |
Exon Therapeutics Llp
ACE-2491
|
Designated Partner | 04 Dec 2023 | 2023 | Active |
Epsilona Ventures Llp
ACD-2264
|
Designated Partner | 04 Oct 2023 | 2023 | Active |
Droid Med Technology Private Limited
U62091GJ2023PTC146142
|
Director | 08 Nov 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Jivrajbhai Vaghani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Jivrajbhai Vaghani
Sanjay Jivrajbhai Vaghani has 3 years in corporate governance. Holds Partner and Managing Director roles. Currently with 6 companies, including Surat Institute Of Medical Science Llp and Universal Superspeciality Hospital Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Sanjay Jivrajbhai Vaghani is associated with 6 companies as Partner and Managing Director.
Sanjay Jivrajbhai Vaghani has expertise in General Business, Technology.
Sanjay Jivrajbhai Vaghani has 3 years in corporate governance.